# Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis

> **NCT00116181** · PHASE3 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 30 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00116181
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2011-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116181, "Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00116181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*